Menu Back to Clinical-Trials-Workshop-II-Translating-the-New-Transparency-Requirements-into-Practice

Program Committee

  • Sabine  Atzor, RPh
    Sabine Atzor, RPh Director Regulatory Affairs , EFPIA, Belgium
    On Secondment From F. Hoffmann-La Roche, Switzerland
  • Nick  Sykes, MS
    Nick Sykes, MS Senior Director, Worldwide Regulatory Strategy
    Pfizer Ltd., United Kingdom
  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Director, Global Clinical Registry
    Novo Nordisk A/S, Denmark
  • Hanns-Georg  Leimer, PhD
    Hanns-Georg Leimer, PhD Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti
    Boehringer Ingelheim Pharma GmbH&CO KG, Germany
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
Load More